Professor Andrew Hopper

MB ChB FRCP MD

Clinical Medicine, School of Medicine and Population Health

Honorary Professor of Gastroenterology and Consultant Gastroenterologist

a.hopper@sheffield.ac.uk
+44 114 226 5948

Room P06, P Floor, Royal Hallamshire Hospital

Full contact details

Professor Andrew Hopper
Clinical Medicine, School of Medicine and Population Health
Room P06, P Floor
Royal Hallamshire Hospital
Glossop Road
Sheffield
S10 2JF

Profile: I am a Honorary Professor and Consultant Gastroenterologist in Gastroenterology at The University of Sheffield & the Royal Hallamshire Hospital. I am a nationally recognised expert in advanced endoscopic therapy, chronic pancreatitis and pancreatic and upper gastro-intestinal cancer. I am pioneering novel imaging and therapeutic techniques in pancreatic disease. I am a co-author of the recent European and National Consensus guidelines in the management of Pancreatic Disease (2017 & 2020). My achievements in training, teaching, academic and managerial roles incorporating these specialist interests have led to recognition and increased profile of our department both nationally and internationally including our departments being recognised as a World Endoscopy Organisation (WEO) accredited unit and European neuroendocrine tumour centre of excellence.

Research interests: I am an active researcher in the areas of pancreatic disease, novel endoscopic techniques and academic gastroenterology. I am now the author or co-author of over 80 peer-reviewed journal manuscripts 134 publications and with 1324 citations and a 'H'-index score of 21. In the last 5 years I have completed supervision of 2 research fellows who were both awarded a higher degree (MD) from the University of Sheffield in the diagnosis of chronic pancreatitis.

Publications

Show: Featured publications All publications

Featured publications

Journal articles

Damm M, Efremov L, Jalal M, Nadeem N, Dober J, Michl P, Wohlgemuth W, Wadsley J, Hopper A, Krug S & Rosendahl J (2022) Body composition parameters as survival predictors in patients with pancreatic cancer – A retrospective multicenter analysis. Zeitschrift für Gastroenterologie, 60(08), e530-e530.
Hopper AD (2022) Role of endoscopy in patients with familial adenomatous polyposis. Frontline Gastroenterology, 13(e1), e72-e79.
Ching H-L, Lau MS, Azmy IA, Hopper AD, Keuchel M, Gyökeres T, Kuvaev R, Macken EJ, Bhandari P, Thoufeeq M , Leclercq P et al (2022) Performance measures for the SACRED team-centered approach to advanced gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy, 54(07), 712-722.
Jalal M, Rosendahl J, Campbell JA, Vinayagam R, Al-Mukhtar A & Hopper AD (2022) Identification of “Digital Sarcopenia” Can Aid the Detection of Pancreatic Exocrine Insufficiency and Malnutrition Assessment in Patients with Suspected Pancreatic Pathology. Digestive Diseases, 40(3), 335-344.
Jalal M, Campbell JA, Tesfaye S, Al-Mukhtar A & Hopper AD (2021) Yield of testing for micronutrient deficiencies associated with pancreatic exocrine insufficiency in a clinical setting: an observational study. World Journal of Clinical Cases, 9(36), 11320-11329. View this article in WRRO
Jalal M, Campbell JA, Wadsley J & Hopper AD (2021) Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management. Journal of Gastrointestinal Cancer, 52(3), 1183-1187.
Phillips ME, Hopper AD, Leeds JS, Roberts KJ, McGeeney L, Duggan SN & Kumar R (2021) Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterology, 8(1), e000643-e000643.
Boger P, Rahman I, Hu M, Ayaru L, Bhandari P, Chedgy F, Green S, Hayat M, Hopper AD, Ishaq S , Martin J et al (2021) Endoscopic full thickness resection in the colo-rectum: outcomes from the UK Registry. European Journal of Gastroenterology & Hepatology, 33(6), 852-858.
Jalal M, Campbell JA & Hopper AD (2019) Practical guide to the management of chronic pancreatitis. Frontline Gastroenterology, 10(3), 253-260.
Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM, Löhr M, Dominguez-Munoz JE, Besselink M , Mayerle J et al (2018) Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology, 18(8), 847-854.
Löhr JM, Dominguez‐Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias‐Garcia J , Keller J et al (2017) United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterology Journal, 5(2), 153-199.
Campbell JA, Irvine AJ & Hopper AD (2016) Endoscopic ultrasound sedation in the United Kingdom: Is life without propofol tolerable?. World Journal of Gastroenterology, 23(3), 560-562. View this article in WRRO
Swan MP, Bourke MJ, Moss A, Williams SJ, Hopper A & Metz A (2011) The target sign: an endoscopic marker for the resection of the muscularis propria and potential perforation during colonic endoscopic mucosal resection. Gastrointestinal Endoscopy, 73(1), 79-85.
Swan MP, Bourke MJ, Hopper AD, Kwan V & Williams SJ (2010) Autoimmune pancreatitis: an important diagnostic consideration in obstructive jaundice due to a pancreatic mass lesion. Internal Medicine Journal, 40(10), 720-725.
Hopper AD, Bourke MJ, Williams SJ & Swan MP (2010) Giant laterally spreading tumors of the papilla: endoscopic features, resection technique, and outcome (with videos). Gastrointestinal Endoscopy, 71(6), 967-975.

Conference proceedings papers

Hopper AD (2014) Early endoscopy improves survival in gastric cancer. Practitioner, Vol. 258(1773) (pp 23-27)

Preprints

Jalal M, Campbell JA, Wadsley J & Hopper AD (2021) Digital Detection of Sarcopenia in Pancreatic Cancer: Additional Utilization to Plan Patient Management, Research Square Platform LLC.

All publications

Journal articles

Shiha MG, Nandi N, Oka P, Raju SA, Penny HA, Hopper AD, Elli L & Sanders DS (2023) Narrow-band imaging for optical diagnosis of duodenal villous atrophy in patients with suspected coeliac disease: A systematic review and meta-analysis. Digestive and Liver Disease.
Mitra V, Munnelly S, Grammatikopoulos T, Mole D, Hopper A, Ryan B, Phillips M, Tarpey M & Leeds J (2023) The top 10 research priorities for pancreatitis: findings from a James Lind Alliance priority setting partnership. The Lancet Gastroenterology & Hepatology.
Raju SA, Ching H-L, Jalal M, Lau MS, Rej A, Tai FWD, Tun G, Hopper AD, McAlindon ME, Sidhu R , Thoufeeq M et al (2022) Does reverse mentoring work in the NHS: a feasibility study of clinicians in practice. BMJ Open, 12(11).
Damm M, Efremov L, Jalal M, Nadeem N, Dober J, Michl P, Wohlgemuth W, Wadsley J, Hopper A, Krug S & Rosendahl J (2022) Body composition parameters as survival predictors in patients with pancreatic cancer – A retrospective multicenter analysis. Zeitschrift für Gastroenterologie, 60(08), e530-e530.
Hopper AD (2022) Role of endoscopy in patients with familial adenomatous polyposis. Frontline Gastroenterology, 13(e1), e72-e79.
Ching H-L, Lau MS, Azmy IA, Hopper AD, Keuchel M, Gyökeres T, Kuvaev R, Macken EJ, Bhandari P, Thoufeeq M , Leclercq P et al (2022) Performance measures for the SACRED team-centered approach to advanced gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy, 54(07), 712-722.
Jalal M, Rosendahl J, Campbell JA, Vinayagam R, Al-Mukhtar A & Hopper AD (2022) Identification of “Digital Sarcopenia” Can Aid the Detection of Pancreatic Exocrine Insufficiency and Malnutrition Assessment in Patients with Suspected Pancreatic Pathology. Digestive Diseases, 40(3), 335-344.
Jalal M, Campbell JA, Tesfaye S, Al-Mukhtar A & Hopper AD (2021) Yield of testing for micronutrient deficiencies associated with pancreatic exocrine insufficiency in a clinical setting: an observational study. World Journal of Clinical Cases, 9(36), 11320-11329. View this article in WRRO
Jalal M, Campbell JA, Wadsley J & Hopper AD (2021) Computed Tomographic Sarcopenia in Pancreatic Cancer: Further Utilization to Plan Patient Management. Journal of Gastrointestinal Cancer, 52(3), 1183-1187.
Phillips ME, Hopper AD, Leeds JS, Roberts KJ, McGeeney L, Duggan SN & Kumar R (2021) Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterology, 8(1), e000643-e000643.
Boger P, Rahman I, Hu M, Ayaru L, Bhandari P, Chedgy F, Green S, Hayat M, Hopper AD, Ishaq S , Martin J et al (2021) Endoscopic full thickness resection in the colo-rectum: outcomes from the UK Registry. European Journal of Gastroenterology & Hepatology, 33(6), 852-858.
Shiha M, Laidlaw S, Hunt L & Hopper AD (2021) ‘Blast from the past’ colonoscopy complication treated with a novel approach. Gut, 70(3), 475-554.
Shiha MG, Hopper AD, Campbell JA & Sanders DS (2020) Letter: the under-treatment and under-diagnosis of pancreatic exocrine insufficiency in chronic pancreatitis and pancreatic cancer is just the tip of the iceberg. Alimentary Pharmacology & Therapeutics, 52(4), 742-743.
Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM, Löhr M, Dominguez-Munoz JE, Besselink M , Mayerle J et al (2020) Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” [Pancreatology 18(8) (2018) 847–854]. Pancreatology, 20(1), 148-148.
Tai FWD, Wray N, Sidhu R, Hopper A & McAlindon M (2020) Factors associated with oesophagogastric cancers missed by gastroscopy: a case–control study. Frontline Gastroenterology, 11(3), 194-201.
Al-Rifaie A, El-Feki M, Al-Talib I, Abdulwahid M, Hopper A & Thoufeeq M (2020) Does the withdrawal time affect adenoma detection in non-screening colonoscopies?. Frontline Gastroenterology, 11(1), 5-10.
Jalal M, Campbell JA, Wadsley J & Hopper AD (2019) Can digital skeletal muscle index predict palliative chemotherapy uptake before patients undergo endoscopic pancreatic biopsy?. Pancreatology, 19, S106-S107.
Jalal M & Hopper AD (2019) Are we missing cases of pancreatic exocrine insufficiency in hospitalised patients with high alcohol intake?. Pancreatology, 19, S87-S88.
Jalal M, Campbell JA, Wadsley J & Hopper AD (2019) OWE-29 Can digital skeletal muscle index predict palliative chemotherapy uptake before patients undergo endoscopic pancreatic biopsy?. Pancreas.
Jalal M, Campbell JA & Hopper AD (2019) Can serum nutritional markers be used for diagnosing pancreatic exocrine insufficiency in at risk groups?. Pancreatology, 19, S134-S134.
Hopper AD, Jalal M & Munir A (2019) Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours. Frontline Gastroenterology, 10(3), 269-274.
Jalal M, Campbell JA & Hopper AD (2019) Practical guide to the management of chronic pancreatitis. Frontline Gastroenterology, 10(3), 253-260.
Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM, Löhr M, Dominguez-Munoz JE, Besselink M , Mayerle J et al (2018) Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology, 18(8), 847-854.
Kurien M, Hopper A, Lobo AJ, McAlindon ME, Sidhu R, Gleeson DC, Hebden JM, Basu K, Panter S, Lockett M & Sanders DS (2018) Sheffield Clinical Research Fellowship programme: a transferable model for UK gastroenterology. Frontline Gastroenterology, 9(4), 325-330. View this article in WRRO
Campbell JA, Hampton JNS, Löhr M, Howard C, Sanders DS & Hopper AD (2018) The prevalence of pancreatic morphological abnormalities detected by digital autopsy. Pancreatology, 18(7), 717-720.
Jalal M & Hopper AD (2018) Diagnosis and management of oesophageal cancer. Practitioner, 262(1812), 21-25.
Hopper AD & Campbell JA (2018) Improving future studies in chronic pancreatitis: a paradigm shift in our understanding?. Gut, 67(7), 1365-1366.
Schembri J, Hopper A & Thoufeeq M (2017) Experienced endoscopists improve Barrett’s surveillance outcomes independently of time allocation. Endoscopy, 49(11), 1114-1114.
Hopper AD, Campbell JA & Sanders DS (2017) Improving Outcomes of Chronic Pancreatitis: Is Isolated Pancreatic Exocrine Insufficiency an Early Marker to Identify Modifiable Risks?. The American Journal of Gastroenterology, 112(5), 813-814.
Löhr JM, Dominguez‐Munoz E, Rosendahl J, Besselink M, Mayerle J, Lerch MM, Haas S, Akisik F, Kartalis N, Iglesias‐Garcia J , Keller J et al (2017) United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU). United European Gastroenterology Journal, 5(2), 153-199.
Campbell JA, Irvine AJ & Hopper AD (2016) Endoscopic ultrasound sedation in the United Kingdom: Is life without propofol tolerable?. World Journal of Gastroenterology, 23(3), 560-562. View this article in WRRO
Campbell JA, Sanders DS, Francis KA, Kurien M, Lee S, Taha H, Ramadas A, Joy D & Hopper AD (2016) Should we investigate gastroenterology patients for pancreatic exocrine insufficiency? A dual centre UK study. Journal of Gastrointestinal and Liver Diseases, 25(3), 303-309. View this article in WRRO
Lau MS, Hopper AD & Sanders DS (2016) Improving the detection of coeliac disease. Practitioner, 260(1795), 13-17.
Hopper AD, Mooney PD & Blakeborough A (2016) Identifying the ‘Right’ colon lesion. Gut, 65(12), 1959-1959.
Hopper AD & Campbell JA (2016) Early diagnosis of oesophageal cancer improves outcomes. Practitioner, 260(1791), 23-28.
Hopper AD, Gosling D, Patwary S, Partridge D & Peterson M (2016) Seeing a cause for blindness in severe pancreatitis. Gut, 65(1), 32-32.
Irvine AJ, Sanders DS, Hopper A, Kurien M & Sidhu R (2016) How does tolerability of double balloon enteroscopy compare to other forms of endoscopy?. Frontline Gastroenterology, 7(1), 41-46.
He Y, Liu S, Kling DE, Leone S, Lawlor NT, Huang Y, Feinberg SB, Hill DR & Newburg DS (2016) The human milk oligosaccharide 2′-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. Gut, 65(1), 33-46.
Mooney PD, Evans KE, Kurien M, Hopper AD & Sanders DS (2015) Gastro-oesophageal reflux symptoms and coeliac disease. European Journal of Gastroenterology & Hepatology, 27(6), 692-697.
Mooney PD, Kurien M, Wong SH, Rosario EM, Burden M, Hopper A & Sanders DS (2015) 848 Adult Coeliac Disease Isolated to the Duodenal Bulb - A Different Phenotype to Conventional Disease?. Gastroenterology, 148(4), S-169.
Hopper AD (2015) Improving the diagnosis and management of GORD in adults. Practitioner, 259(1781), 27-32.
Penny HA, Leeds JS, Kurien M, Averginos A, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2015) The relationship between inflammatory bowel disease and type 1 diabetes mellitus: A study of relative prevalence in comparison with population controls. Journal of Gastrointestinal and Liver Diseases, 24(1), 125-126. View this article in WRRO
Fielding J, Hawley A, Hardcastle S, Drew K, Gleeson D, Karajeh M, Sanders D, Hopper A, Sidhu R, McAlindon M & Lobo AJ (2014) OC-041 Reduced Hospital Admission And Rapid Access To Specialist Services Through The Introduction Of A Gastroenterology And Hepatology Ambulatory Care Service: Abstract OC-041 Table 1. Gut, 63(Suppl 1), A20.1-A20.
Taylor E, Din S, Campbell J & Hopper A (2014) PTU-147 Validation Of Updated Barrett’s Oesophagus Guideline Recommendations: Complications And Outcomes Of An ‘adequate’ Case Volume And The Feasibility Of Same Day Discharge. Gut, 63(Suppl 1), A103.1-A103.
Mooney PD, Kurien M, Johnston AJ, Wong SH, Hopper A, Cross SS & Sander DS (2014) Su1448 Duodenal Bulb Biopsies for the Diagnosis of Celiac Disease. Gastroenterology, 146(5).
Kurien M, Ejenavi E, Hopper AD & Sanders DS (2014) Is British gastroenterology research in decline?. European Journal of Gastroenterology & Hepatology, 26(6), 686-687.
Mooney PD, Leeds JS, Libzo N, Sidhu R, Evans KE, Hall EJ, Jandu VS, Hopper AD, Basumani P, Dear KL , McAlindon ME et al (2014) Case-finding for coeliac disease in secondary care: A prospective multicentre UK study. Digestive and Liver Disease, 46(1), 32-35.
Hopper AD, Vinayagam R & Dube A (2013) OC-042 Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Mass Lesions can be Less Accurate with a Metallic Stent in Situ but should not Delay Treatment of Obstructive Jaundice. Gut, 62(Suppl 1), A18.3-A19.
Kurien M, Leeds JS, Hopper AD, Wild G, Egner W, Tesfaye S, Hadjivassiliou M & Sanders DS (2013) Serological testing for coeliac disease in Type 1 diabetes mellitus: is immunoglobulin A level measurement necessary?. Diabetic Medicine, 30(7), 840-845.
Kurien M, Hopper AD, Barker J, Peerally MF, Fielding J & Sanders DS (2013) Is research declining amongst gastroenterology trainees in the United Kingdom?. Clinical Medicine, 13(1), 118.2-119.
Swallow K, Wild G, Sargur R, Sanders DS, Aziz I, Hopper AD & Egner W (2012) Quality not quantity for transglutaminase antibody 2: the performance of an endomysial and tissue transglutaminase test in screening coeliac disease remains stable over time. Clinical and Experimental Immunology, 171(1), 100-106.
Warriner DR, Morris PD, Kanaan MZ, Collins MC & Hopper AD (2012) . BMJ, 344(jun13 2), e3992-e3992.
Kurien M, Evans KE, Hopper AD, Hale MF, Cross SS & Sanders DS (2012) Duodenal bulb biopsies for diagnosing adult celiac disease: is there an optimal biopsy site?. Gastrointestinal Endoscopy, 75(6), 1190-1196.
Aziz I, Evans KE, Hopper AD, Smillie DM & Sanders DS (2012) OC-102 Coeliac disease, anti-inflammatory drugs orHelicobacter pyloriare the most common identifiable causes of lymphocytic duodenosis. Gut, 61(Suppl 2), A44.2-A45.
Hopper AD, Irvine A, Vinayagam R & Dube A (2012) PMO-004 Do we need propofol sedation and a cytologist present during endoscopic ultrasound? Initial experience from a UK centre. Gut, 61(Suppl 2), A74.1-A74.
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2012) Response to Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163. Diabetes Care, 35(2), e12-e12.
Kurien M, Hopper AD & Sanders DS (2012) Response. Gastrointestinal Endoscopy, 76(5), 1082-1082.
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2011) High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care, 34(10), 2158-2163. View this article in WRRO
Hopper AD & Sanders DS (2011) Upper GI bleeding requires prompt investigation. Practitioner, 255(1742), 15-19.
Evans KE, Aziz I, Cross SS, Sahota GRK, Hopper AD, Hadjivassiliou M & Sanders DS (2011) A Prospective Study of Duodenal Bulb Biopsy in Newly Diagnosed and Established Adult Celiac Disease. American Journal of Gastroenterology, 106(10), 1837-1742.
Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A & Sanders DS (2011) Bile acid malabsorption: An under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scandinavian Journal of Gastroenterology, 46(7-8), 818-822.
Swan MP, Bourke MJ, Moss A, Williams SJ, Hopper A & Metz A (2011) The target sign: an endoscopic marker for the resection of the muscularis propria and potential perforation during colonic endoscopic mucosal resection. Gastrointestinal Endoscopy, 73(1), 79-85.
Swan MP, Bourke MJ, Hopper AD, Kwan V & Williams SJ (2010) Autoimmune pancreatitis: an important diagnostic consideration in obstructive jaundice due to a pancreatic mass lesion. Internal Medicine Journal, 40(10), 720-725.
Aziz I, Evans KE, Hopper AD, Smillie DM & Sanders DS (2010) A prospective study into the aetiology of lymphocytic duodenosis. Alimentary Pharmacology & Therapeutics, 32(11-12), 1392-1397.
Hopper AD, Bourke MJ, Williams SJ & Swan MP (2010) Giant laterally spreading tumors of the papilla: endoscopic features, resection technique, and outcome (with videos). Gastrointestinal Endoscopy, 71(6), 967-975.
Swan M, Bourke M, Hopper A, Moss A & Walker S (2010) Endoscopic treatment of a transversely impacted perforating fish bone in the esophagus with pneumomediastinum. Endoscopy, 42(S 02), E75-E76.
Moss A, Bourke MJ, Kwan V, Tran K, Godfrey C, McKay G & Hopper AD (2010) Succinylated gelatin substantially increases en bloc resection size in colonic EMR: a randomized, blinded trial in a porcine model. Gastrointestinal Endoscopy, 71(3), 589-595.
Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, Swan MP, Hopper AD, Kwan V & Bailey AA (2010) Endoscopic Resection for Barrett's High-Grade Dysplasia and Early Esophageal Adenocarcinoma: An Essential Staging Procedure With Long-Term Therapeutic Benefit. American Journal of Gastroenterology, 105(6), 1276-1283.
Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, Morley S & Sanders DS (2010) Some Patients With Irritable Bowel Syndrome May Have Exocrine Pancreatic Insufficiency. Clinical Gastroenterology and Hepatology, 8(5), 433-438.
Hopper AD, Kurien M & Sanders DS (2009) Declining Gastroenterology Research in the United Kingdom. Can the Research Grant Program Stop a Similar Rot in the United States?. American Journal of Gastroenterology, 104(12), 3104-3105.
Hopper AD, Bourke MJ, Hourigan LF, Tran K, Moss A & Swan MP (2009) En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy. Journal of Gastroenterology and Hepatology, 24(9), 1516-1521.
Hopper AD & Sanders DS (2009) In response. Clinical Medicine, Journal of the Royal College of Physicians of London, 9(3), 296-297.
Hopper AD & Sanders DS (2009) The Duodenal Bulb Biopsy “Myth”: Is There Now Enough Evidence to Change Clinical Practice?. Journal of Clinical Gastroenterology, 43(7), 692-692.
Leeds JS, Hopper AD, Hadjivasslliou M, Tesfaye S & Sanders DS (2009) What are the implications of newly-identified coeliac disease in patients with type 1 diabetes mellitus? Effect on glycaemic control, quality of life, cardiac risk factors and peripheral nerve function. Proceedings of the Nutrition Society, 68(OCE1).
Hopper AD, Atkinson RJ, Razak A, Rahim A, Perera A, Jones G & Sanders DS (2009) Is medical research within the UK in decline? A study of publication rates from the British Society of Gastroenterology from 1994 to 2002. Clinical Medicine, 9(1), 22-25.
Hopper AD & Sanders DS (2009) Obtaining duodenal biopsy specimens for celiac disease: is site as important as number?. Gastrointestinal Endoscopy, 69(2), 389-390.
Hopper AD & Sanders DS (2009) Is medical research in the UK in decline? In response. CLINICAL MEDICINE, 9(3), 296-297.
Chew TS, Hopper AD & Sanders DS (2008) Is there a role for routine duodenal biopsy in diagnosing giardiasis in a European population?. Scandinavian Journal of Gastroenterology, 43(10), 1219-1223.
Hopper AD & Sanders DS (2008) Reply. Clinical Gastroenterology and Hepatology, 6(10), 1173-1174.
Leeds JS, Hopper AD, Tesfaye S & Sanders DS (2008) 843 A Prospective Study of the Prevalence of Gastrointestinal Symptoms in Patients with Type 1 Diabetes Mellitus and Correlation with Diabetes Control and Quality of Life. Gastroenterology, 134(4), A-122.
Leeds JS, Hopper AD, Morley S, Hurlstone DP & Sanders DS (2008) S1311 The Relationship Between Exocrine Pancreatic Hypofunction and Patients Fulfilling the ROME II Criteria for Irritable Bowel Syndrome (Diarrhea Predominant, D-IBS): A Prevalence Study with Controls and Therapeutic Outcomes. Gastroenterology, 134(4).
Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, Wild G & Sanders DS (2008) What Is the Role of Serologic Testing in Celiac Disease? A Prospective, Biopsy-Confirmed Study With Economic Analysis. Clinical Gastroenterology and Hepatology, 6(3), 314-320.
Sidhu R, Sakellariou P, McAlindon ME, Leeds JS, Shafiq K, Hoeroldt BS, Hopper AD, Karmo M, Salmon C, Elphick D , Ali A et al (2008) Is formal training necessary for capsule endoscopy?. Digestive and Liver Disease, 40(4), 298-302.
Sanders DS, Hopper AD, Leeds JS & Hadjivassiliou M (2008) But where does it take us?. BMJ, 336(7634), 9.
Sanders DS, Hopper AD, Leeds JS & Hadjivassiliou M (2008) But where does it take us?. BMJ, 336(7634), 9.2-9.
Leeds JS, Höroldt BS, Sidhu R, Hopper AD, Robinson K, Toulson B, Dixon L, Lobo AJ, McAlindon ME, Hurlstone DP & Sanders DS (2007) Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls. Scandinavian Journal of Gastroenterology, 42(10), 1214-1220.
Sanders DS, Hopper AD, Azmy IAF & Hurlstone DP (2007) Is there an association between adult coeliac disease and non-specific abdominal pain?. Scandinavian Journal of Gastroenterology, 42(7), 896-897.
Sidhu R, Arasaradnam RP, McAlindon ME, Kapur K, Hopper AD, Jalil S & Sanders DS (2007) Endoscopic Terminal Ileum Biopsies—Is Nonsteroidal Anti-Inflammatory Drug (NSAID) Induced Enteropathy Responsible for Some of the Macroscopic Abnormalities?. The American Journal of Gastroenterology, 102(11), 2610-2611.
Hopper AD, Hadjivassiliou M, Butt S & Sanders DS (2007) Adult coeliac disease. BMJ, 335(7619), 558-562.
Hopper AD, Cross SS, Hurlstone DP, McAlindon ME, Lobo AJ, Hadjivassiliou M, Sloan ME, Dixon S & Sanders DS (2007) Pre-endoscopy serological testing for coeliac disease: evaluation of a clinical decision tool. BMJ, 334(7596), 729-729. View this article in WRRO
Leeds JS, Hopper AD, Sanders DS, Hadjivassiliou M & Tesfaye S (2007) Prospective study of the prevalence of coeliac disease in adults with Type 1 diabetes mellitus: effect upon glycaemic control and quality of life. DIABETIC MEDICINE, 24, 7-8.
Hopper AD, Sidhu R, Hurlstone DP, McAlindon ME & Sanders DS (2007) Capsule endoscopy: An alternative to duodenal biopsy for the recognition of villous atrophy in coeliac disease?. Digestive and Liver Disease, 39(2), 140-145.
Hopper AD, Hurlstone DP, Leeds JS, McAlindon ME, Dube AK, Stephenson TJ & Sanders DS (2006) The occurrence of terminal ileal histological abnormalities in patients with coeliac disease. Digestive and Liver Disease, 38(11), 815-819.
Hopper AD, Horoldt BS, Stephenson TJ & Sanders DS (2005) Variability of Histologic Lesions in Relation to Biopsy Site in Gluten-Sensitive Enteropathy-What Are the Implications for Diagnosing Adult Celiac Disease?. The American Journal of Gastroenterology, 100(9), 2128-2128.
Sanders DS, Hopper AD, Azmy IAF, Rahman N, Hurlstone DP, Leeds JS, George RR & Bhala N (2005) Association of Adult Celiac Disease With Surgical Abdominal Pain. Annals of Surgery, 242(2), 201-207.
Hopper AD, Leeds JS, Hurlstone DP, Hadjivassiliou M, Drew K & Sanders DS (2005) Are lower gastrointestinal investigations necessary in patients with coeliac disease?. European Journal of Gastroenterology & Hepatology, 17(6), 617-621.
Hopper AD, Atkinson R, Prtak L & Sanders DS (2004) Research trends in British gastroenterology: Publication rates in newly appointed NHS consultants over a nine year period [2]. Gut, 53(6), 913.
Hopper AD, Cross SS, McAlindon ME & Sanders DS (2003) Symptomatic giardiasis without diarrhea: Further evidence to support the routine duodenal biopsy?. Gastrointestinal Endoscopy, 58(1), 120-122.
Parr H, Thomas L, Singh P, Mohammed S, Nu K, Kane JS, Lee F, Welbank T, Hopper AD, McAlindon ME , Williams EA et al () A retrospective study of outcomes and the validation of the Sheffield Gastrostomy Score in PEGs, RIGs and PIGs. Scandinavian Journal of Gastroenterology, 1-5.
Parr H, Williams EA, White S, Thompson N, McAlindon ME, Hopper AD, McKinlay A & Sanders DS () What is the current provision of service for gastrostomy insertion in England?. Frontline Gastroenterology.
Leeds JS, Hopper AD & Sanders DS () Coeliac disease. British Medical Bulletin, 88(1), 157-170.
Hopper A, Chew T, Lewis A & Sanders D () Is there a case for routine duodenal biopsy at gastroscopy or is a targeted approach adequate?. Endoscopy, 40(09), 727-730.
Hopper A, Cross S & Sanders D () Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?. Endoscopy, 40(03), 219-224.
LEEDS JS, HOPPER AD, HURLSTONE DP, EDWARDS SJ, MCALINDON ME, LOBO AJ, DONNELLY MT, MORLEY S & SANDERS DS () Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?. Alimentary Pharmacology & Therapeutics, 25(3), 265-271.

Conference proceedings papers

Parr H, Thomas L, Singh P, Mohammed S, Nu K, Kane JS, Lee F, Williams EA, Hopper AD, McAlindon ME & Sanders DS (2023) O4 A retrospective study of outcomes and validation of the sheffield gastrostomy score in radiologically assisted gastrostomies versus percutaneous endoscopic gastrostomies. Oral presentations
Parr H, Williams EA, White S, Hopper AD, McAlindon ME, Thompson N, McKinlay A & Sanders DS (2022) P225 What is the current provision of service for gastrostomy insertion in England?. Poster presentations
Jalal M, Tesfaye S & Hopper A (2021) P254 Are we still missing cases of pancreatic exocrine insufficiency and pancreatic atrophy in diabetes mellitus?. Posters
Jalal M, Campbell J, Vinayagam R, Al-Mukhtar A & Hopper A (2021) O40 High prevalence of sarcopenic obesity in pancreatic exocrine insufficiency patients: a prospective study. Oral
Raju SA, Ching H-L, Jalal M, Lau M, Rej A, David Tai FW, Tun G, Hopper A, McAlindon ME, Sidhu R , Thoufeeq M et al (2021) P400 The first reverse mentoring in a clinical setting: can you teach old dogs new tricks?. Posters
Campbell JA, Jalal M & Hopper AD (2019) OWE-32 Can fine needle biopsy for pancreatic solid lesions improve accuracy with metal biliary stents present?. Pancreas
Jalal M & Hopper AD (2019) PWE-066 Are we missing cases of pancreatic exocrine insufficiency in hospitalised patients with high alcohol intake?. Posters
Jalal M, Campbell JA & Hopper AD (2019) PWE-067 Can serum nutritional markers be used for diagnosing pancreatic exocrine insufficiency in at risk groups?. Posters
Hopper AD & Campbell JA (2018) Improving outcomes in pancreatic cancer. Practitioner, Vol. 262(1817) (pp 11-15)
Jalal M, Wadsley J & Hopper A (2018) PTU-023 Endoscopic ultrasound biopsy prior to palliative treatment for pancreatic cancer: can we prevent unnecessary procedures?. Pancreas
Hu M, Rahman I, Ishaq S, Bhandari P, Pugh S, Green S, Suzuki N, Hopper A, Martin J, Thomas-Gibson S , Patel P et al (2018) ADTH-01 Endoscopic full thickness resection in the colon: 3-year multicentre UK experience. Endoscopy
Tai DFW, Hopper A & McAlindon M (2018) PTH-061 Missed oesophagogastric cancer correlates with higher list intensity but not rates of sedation. Endoscopy
Al-Rifaie A, El-Feki M, Al-Talib I, Abdulwahid M, Hopper A & Thoufeeq M (2018) DOES THE WITHDRAWAL TIME AFFECT ADENOMA DETECTION IN NON-SCREENING COLONOSCOPIES?. ESGE Days 2018 accepted abstracts, 19 April 2018 - 21 April 2018.
Campbell JA & Hopper AD (2017) Chronic pancreatitis may be overlooked and undertreated. Practitioner, Vol. 261(1806) (pp 13-17)
Campbell JA, Vinayagam R, Sanders DS & Hopper AD (2017) AODTH-009 Quantitative elastography is useful in the diagnosis of chronic pancreatitis. Pancreas and Neuroendocrine
Campbell JA & Hopper AD (2016) PTU-150 Simplified Barrett’s Radiofrequency Ablation Technique in The Elderly. Consideration Should Be Given to Balancing The Increased Risks with Benefits. Gut, Vol. 65(Suppl 1) (pp A131.1-A131)
Campbell JA & Hopper AD (2016) PWE-157 EUS Guided Trans-Gastric Pancreatic Pseudocyst Drainage- Does Standard Use of Fluoroscopy Just Complicate Things?: Abstract PWE-157 Table 1. Gut, Vol. 65(Suppl 1) (pp A215.1-A215)
Campbell JA, Sanders DS & Hopper AD (2016) PWE-155 Should Patients with Human Immunodeficiency Virus and Gastrointestinal Symptoms be Routinely Tested for Pancreatic Exocrine Insufficiency?. Gut, Vol. 65(Suppl 1) (pp A214.1-A214)
Campbell JA, Sanders DS, Howard C, Hampton J & Hopper AD (2016) PWE-156 What is The Prevalence of Chronic Pancreatitis at Post Mortem? A Novel Approach Using “Digital Autopsy”. Gut, Vol. 65(Suppl 1) (pp A214.2-A215)
Kurien M, Hopper AD, Akram R, Glover R, Issa A, Peever E, Purves J, Scanu E & Sanders DS (2016) PTH-125 BSG VS UEG – Which Annual Meeting has The Highest Conversion Rate of Abstracts to Full Publication?. Gut, Vol. 65(Suppl 1) (pp A281.1-A281) View this article in WRRO
El-Feki M, Wilson R, Hopper A & Thoufeeq MH (2016) PTU-027 Colonoscopy Withdrawal Time in Non-Screening Colonoscopies. 6 Minutes or Not?. Gut, Vol. 65(Suppl 1) (pp A65.2-A66)
Campbell JA, Francis KA, Kurien M, Hopper AD, Joy D, Lee S, Ramadas A, Taha H & Sanders DS (2015) PWE-208 How common is pancreatic exocrine insufficiency in primary care?. Gut, Vol. 64(Suppl 1) (pp A303.2-A303)
Campbell J, Sanders D, Lee S, Taha H, Ramadas A, McGivern J, Kurien M, Sidhu R, Leeds J, Hopper A & Joy D (2014) PTH-097 How Common Is Pancreatic Exocrine Insufficiency In Secondary Care Gastroenterology Clinics? A Dual Centre Study. Gut, Vol. 63(Suppl 1) (pp A253.1-A253)
Tun GSZ, Wright A, Robinson K, Sidhu R, Hopper A, Sanders DS, McAlindon M, Raza M & Lobo A (2014) PTU-083 Use Of Polymerase Chain Reaction To Detect Mucosal Cytomegalovirus Infection In Patients With Acute Ulcerative Colitis. Gut, Vol. 63(Suppl 1) (pp A75.2-A76)
Hopper AD (2014) Early endoscopy improves survival in gastric cancer. Practitioner, Vol. 258(1773) (pp 23-27)
Kurien M, Hopper AD, Sabbagh R, Beer A & Sanders DS (2013) PTU-009 From Abstract to Full Publication: A 15-Year Review of British Socety of Gastroentorology (BSG) Conference outcomes. Gut, Vol. 62(Suppl 1) (pp A44.3-A45)
Kurien M, Hopper AD, Barker J, Peerally MF, Lunn EJ & Sanders DS (2012) OC-137 Is research declining among gastroenterology trainees?: Abstract OC-137 Figure 1. Gut, Vol. 61(Suppl 2) (pp A59.2-A59)
Irvine AJ, Kurien M, Hopper AD & Sanders DS (2012) OC-145 Endoscopic procedure related tolerability: discomfort is worse at colonoscopy by comparison to distress at gastroscopy?. Gut, Vol. 61(Suppl 2) (pp A62.3-A63)
Hale MF, Kurien M, Basumani P, Slater R, Sanders DS & Hopper AD (2012) PTU-233 In vivo polyp size and histology assessment at colonoscopy: are we ready to resect and discard? a multi-centre analysis of 1212 polypectomies. Gut, Vol. 61(Suppl 2) (pp A280.2-A281)
Kurien M, Evans KE, Aziz I, Cross SS, Hopper AD, Hadjivassiliou M & Sanders DS (2012) OC-049 Duodenal bulb biopsies—are they a necessity in coeliac disease?: Abstract OC-049 Table 1. Gut, Vol. 61(Suppl 2) (pp A21.2-A22)
Kurien M, Evans KE, Hopper AD, Hale MF, Cross SS & Sanders DS (2012) PWE-119 Duodenal bulb biopsies for diagnosing adult coeliac disease: is there an optimal biopsy site?: Abstract PWE-119 Table 1. Gut, Vol. 61(Suppl 2) (pp A345.2-A345)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2011) Potential coeliac disease in type 1 diabetes mellitus: does a positive antibody lead to increased complications?. Gut, Vol. 60(Suppl 1) (pp A87-A87)
Kurien M, Evans KE, Leeds JS, Hopper AD, Harris A, Hanney M & Sanders DS (2011) Bile acid malabsorption a differential diagnosis for patients presenting with diarrhoea predominant irritable bowel syndrome type symptoms?. Gut, Vol. 60(Suppl 1) (pp A160-A161)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2011) Inflammatory bowel disease is more common in type 1 diabetes mellitus. Gut, Vol. 60(Suppl 1) (pp A208-A208)
Leeds JS, Aziz I, Sidhu R, Hopper AD, Evans KE, Morley S & Sanders DS (2011) * Is there a role for faecal elastase-1 in patients referred to a luminal gastroenterology service?. Gut, Vol. 60(Suppl 1) (pp A252-A252)
Evans KE, Cross SS, Sahota GR, Hopper AD, Hadjivassiliou M & Sanders DS (2011) Routine duodenal bulb biopsy in coeliac disease: time to change clinical practice?. Gut, Vol. 60(Suppl 1) (pp A53-A53)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2011) Effect of irritable bowel symptoms on quality of life in people with and without type 1 diabetes mellitus. Gut, Vol. 60(Suppl 1) (pp A161-A162)
Aziz I, Evans KE, Hopper AD & Sanders DS (2010) OC-080 A systematic approach identifying the causes of duodenal intraepithelial lymphocytosis: Abstract OC-080. Gut, Vol. 59(Suppl 1) (pp A33.2-A33)
Leeds JS, Hopper AD, Egner W, Wilde G, Tesfaye S, Hadjivassiliou M & Sanders DS (2010) PTH-090 Prevalence of IgA deficiency in patients with type 1 diabetes and the effect on detection of coeliac disease: are NICE guidelines appropriate?. Gut, Vol. 59(Suppl 1) (pp A160.1-A160)
Evans KE, Cross SS, Sahota GR, Hopper AD, Hadjivassiliou M & Sanders DS (2010) PTH-087 Routine duodenal bulb biopsy in coeliac disease: a paradigm shift in our clinical practice?: Abstract PTH-087. Gut, Vol. 59(Suppl 1) (pp A158.2-A159)
Leeds JS, Libzo N, Sidhu R, Evans KE, Kurien M, Hall EJ, Jandu VS, Hopper AD, Basumani P, Dear KL , McAlindon ME et al (2010) OC-081 Can a “risk of coeliac disease” scoring system reduce the number of patients referred for duodenal biopsy?. Gut, Vol. 59(Suppl 1) (pp A33.3-A34)
Leeds JS, Hopper AD, Tesfaye S, Hadjivassiliou M & Sanders DS (2010) PTH-075 Is there a need for combined gastrointestinal and diabetes clinics? A prospective study of the prevalence of diarrhoea in patients with type 1 diabetes mellitus and findings on investigation. Gut, Vol. 59(Suppl 1) (pp A153.3-A154)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2010) PTH-089 Coeliac disease increases the risk of microvascular complications in patients with type 1 diabetes mellitus. Gut, Vol. 59(Suppl 1) (pp A159.2-A159)
Kurien M, Evans KE, Leeds JS, Hopper AD, Harris AM & Sanders DS (2010) PTH-100 Increasing the detection rate of bile salt malabsorption. Gut, Vol. 59(Suppl 1) (pp A164.1-A164)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2009) WHAT ARE THE IMPLICATIONS OF NEWLY IDENTIFIED COELIAC DISEASE IN ADULT PATIENTS WITH TYPE 1 DIABETES MELLITUS? EFFECT UPON GLYCAEMIC CONTROL, QUALITY OF LIFE, CARDIAC RISK FACTORS, ALBUMINURIA AND PERIPHERAL NERVE FUNCTION. GUT, Vol. 58 (pp A118-A118)
Hopper AD, Chew TS, Wild G & Sanders DS (2008) Is tissue transglutaminase antibody an accurate predictor of marsh grade in both newly diagnosed and treated patients with coeliac disease?. GUT, Vol. 57 (pp A169-A169)
Hopper AD, Chew TS & Sanders DS (2008) Is there a case for routine duodenal biopsy at gastroscopy or is a targeted approach adequate? a retrospective and prospective evaluation. GUT, Vol. 57 (pp A52-A53)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2008) What are the implications of newly identified coeliac disease in patients with type 1 diabetes mellitus? Effect upon glycaemic control, quality of life, cardiac risk factors and peripheral nerve function. GUT, Vol. 57 (pp A21-A21)
Leeds JS, Hopper AD, Tesfaye S & Sanders DS (2008) A prospective study of the prevalence of gastrointestinal symptoms in patients with type 1 diabetes mellitus and correlation with diabetes control and quality of life. GUT, Vol. 57 (pp A156-A157)
Hopper AD, Cross SS, Hurlstone DP & Sanders DS (2007) What is the optimal site and number of endoscopic duodenal biopsies required to diagnose coeliac disease?. GUT, Vol. 56 (pp A32-A33)
Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2007) Prospective study of the prevalence of coeliac disease in adults with type 1 diabetes mellitus: Effect upon glycaemic control and quality of life. GUT, Vol. 56 (pp A33-A33)
Hopper AD, Hurlstone DP, Wild G & Sanders DS (2007) Does tissue transglutaminase sensitivity increase with the severity of villous atrophy in coeliac disease?. GUT, Vol. 56 (pp A143-A143)
Atkinson RJ, Hopper AD, Razak A, Perera A, Rahim A & Sanders DS (2007) Is research within the British Society of Gastroenterology in decline?. GUT, Vol. 56 (pp A43-A43)
Sidhu R, Sakellariou PV, McAlindon ME, Hopper AD, Hoeroldt BS, Leeds JS, Karmo M & Sanders DS (2007) Capsule endoscopy: Is formal training necessary for specialist registrars in gastroenterology?. GUT, Vol. 56 (pp A84-A84)
Leeds JS, Hopper AD, Simmonette A, Azadbakht N, Morley S, Hurlstone DP & Sanders DS (2007) The relation between exocrine pancreatic hypofunction and patients fulfilling the Rome II criteria for irritable bowel syndrome (diarrhoea predominant): A prevalence study with controls and therapeutic outcomes. GUT, Vol. 56 (pp A65-A65)
Hopper AD, Hurlstone DP, Wild G & Sanders DS (2007) What are the best immunological tests for coeliac disease? A prospective assessment of 2000 biopsy verified results. GUT, Vol. 56 (pp A32-A32)
Hopper AD, Hurlstone DP, Leeds JS, Hadjivassiliou M & Sanders DS (2006) Can serological testing for coeliac disease prior to endoscopy reduce the need for routine duodenal biopsy? A prospective analysis of 1500 cases. GUT, Vol. 55 (pp A100-A101)
Horoldt BS, Leeds JS, Sidhu R, Hopper AD, Robinson K, Toulson B, Lobo AJ, McAlindon ME, Hurlstone DP & Sanders DS (2006) Is there a relationship between coeliac disease and inflammatory bowel disease? A bidirectional prevalence study with controls. GUT, Vol. 55 (pp A98-A98)
Leeds JS, Hopper AD, Simmonette A, Azadbakht N, Morley S, Hurlstone DP & Sanders DS (2006) A prospective study of the prevalence of exocrine pancreatic insufficiency in patients with diarrhoea predominant irritable bowel syndrome using faecal elastase-1. GUT, Vol. 55 (pp A97-A98)
Sidhu R, Horoldt BS, Hopper AD, McAlindon ME, Kapur K, Hurlstone DP, Wheeldon MC & Sanders DS (2006) Push enteroscopy in the era of capsule endoscopy. GUT, Vol. 55 (pp A12-A12)
Hopper AD, Hurlstone DP, Leeds JS, McAlindon ME, Dube AK, Stephenson TJ & Sanders DS (2006) Recognising coeliac disease on terminal ileal biopsies: Should intraepithelial lymphocytes be routinely quantified?. GUT, Vol. 55 (pp A100-A100)
Leeds JS, Hopper AD, Edwards SJ, Hurlstone DP, McAlindon ME, Morley S & Sanders DS (2005) The relation between adult coeliac disease and exocrine pancreatic insufficiency: 12 month follow up and intervention data. GUT, Vol. 54 (pp A3-A4)
Hopper AD, Leeds JS, Lewis A, Hurlstone DP, McAlindon ME & Sanders DS (2005) Is routine duodenal biopsy essential to stop coeliac disease being missed at gastroscopy?. GUT, Vol. 54 (pp A105-A105)
Hopper AD, Sanders DS & McAlindon ME (2005) The diagnostic accuracy of capsule endoscopy in coeliac disease: A blinded pilot study. GUT, Vol. 54 (pp A105-A105)
Sanders DS, Hopper AD, Azmy IAF, Rahman N, Hurlstone DP, Leeds JS, George RR & Bhala N (2004) Association of adult coeliac disease with surgical abdominal pain: A case controlled study in patients referred to secondary care. GUT, Vol. 53 (pp A6-A7)
Leeds JS, Hopper AD, Edwards SJ, McAlindon ME, Lobo AJ, Donnelly MT & Sanders DS (2004) Prospective study of the prevalence of exocrine pancreatic insufficiency in adult coeliac disease using faecal elastase-1 (FEL-1). GUT, Vol. 53 (pp A7-A7)
Hopper AD, Leeds JS, Hurlstone DP & Sanders DS (2004) Are lower gastrointestinal investigations necessary in patients with coeliac disease?. GUT, Vol. 53 (pp A7-A7)
Hopper AD, Atkinson RJ, Prtak L & Sanders DS (2003) Research trends in British gastroenterology: Publication rates in newly appointed NHS consultants over a 9 year period. GUT, Vol. 52 (pp A76-A77)

Posters

Leeds JS, Hopper AD, Hadjivassiliou M, Tesfaye S & Sanders DS (2014) Potential coeliac disease in Type 1 diabetes mellitus: Does a positive antibody lead to increased complications?.

Preprints

Jalal M, Campbell JA, Wadsley J & Hopper AD (2021) Digital Detection of Sarcopenia in Pancreatic Cancer: Additional Utilization to Plan Patient Management, Research Square Platform LLC.

Teaching interests

I organize a recurrent large (>100 delegates), national postgraduate pancreatology meeting with international speakers with successful funding to enable it to be free to attend and this also ran on line during the pandemic.

I co-chair the the Annual ‘Bardhan Fellowship’ Postgraduate Meeting: For the last 7 consecutive years I have developed a regional Postgraduate research presentation day for Specialist Registrars and Research Fellows from Yorkshire Deanery as part of this I perform a morning of live endoscopy training.

I have been the principal author or co-author of a number of 17 gastroenterology educational articles, review articles, clinical case based education articles and guidelines for peer reviewed journals

Professional activities and memberships

I am the outgoing elected Chair of the Pancreas committee of the British Society of Gastroenterology (Sept 2017-2020) and President elect for the UK and Ireland Pancreatic Society 2023.

I am the Clinical and Audit Lead for the National Upper Gastrointestinal Cancer for Sheffield Teaching Hospitals.

Current projects: I am continuing my research work with an application currently to look at a unique computer programme to aid research into predicting nutritional status in pancreatic cancer which includes collaborating with European centres.